A study presented at the ongoing European Obesity Summit has confirmed a correlation between the risk of developing high grade prostate cancer and high body mass index and waist circumference.
A study presented at the ongoing European Obesity Summit has confirmed a correlation between the risk of developing high grade prostate cancer and high body mass index (BMI) and waist circumference.
The international study, conducted among nearly 150,000 men across 8 European countries has been called the European Prospective Investigation into Cancer and Nutrition or EPIC trial. The primary goal of this study was to compare the risk of prostate cancer incidence—particularly the stage and grade of the disease—as well as mortality, in men with varying body measurements of BMI and waistline.
At a mean age of 52 years, 141,896 men from Italy, Spain, United Kingdom, the Netherlands, Greece, Germany, Sweden, and Denmark participated in the EPIC study. The data was normalized for education level, smoking marital status, diabetes, and physical activity.
The 14 year follow-up found that a little over 7000 men in the entire cohort developed prostate cancer, of whom 13%, or 934 men, died. The researchers analyzing this data focused their attention on high grade and fatal disease, and found that a majority of men who had a bigger waist circumference or a bigger BMI were more prone to developing an aggressive form of prostate cancer (10% increased risk for BMI for every 5 kg/m2 increase and 13% for waist circumference for every 10 cm increase). Additionally, a 5 kg/m2 increase in BMI raised a person’s risk of dying by 14%, while a 10 cm increase in waist circumference raised that risk to 18%.
Summarizing their findings, the authors state that men who have greater adiposity have an elevated risk of high grade prostate cancer and prostate cancer death.
The association between cancer and obesity is known for a while now, and a recent study published in the journal Nature found that adiposity can trigger changes in stem-cell behavior in the gut. The study showed that mice who were fed a diet of 60% fat for 9-12 months gained 30% to 50% more body weight, and developed more intestinal tumors than mice on a normal diet.
Reference
Higher BMI, waist circumference are associated with increased risk of aggressive prostate cancer. ScienceDaily website. www.sciencedaily.com/releases/2016/06/160602121838.htm. Published 2 June 2016. Accessed June 3, 2016.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More